Pages that link to "Q34756084"
Jump to navigation
Jump to search
The following pages link to Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine (Q34756084):
Displaying 50 items.
- Effect of Iboga alkaloids on µ-opioid receptor-coupled G protein activation (Q21132475) (← links)
- Antidepressants for smoking cessation (Q24201167) (← links)
- Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders (Q24532028) (← links)
- Transdermal delivery of bupropion and its active metabolite, hydroxybupropion: a prodrug strategy as an alternative approach (Q24655598) (← links)
- The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function (Q26821785) (← links)
- Mechanistic insights into nicotine withdrawal (Q27687645) (← links)
- Tobacco addiction and the dysregulation of brain stress systems (Q28111988) (← links)
- New mechanisms and perspectives in nicotine withdrawal (Q28111991) (← links)
- The noradrenergic action in antidepressant treatments: pharmacological and clinical aspects (Q28300843) (← links)
- TC-5214 (S-(+)-mecamylamine): a neuronal nicotinic receptor modulator with antidepressant activity (Q28302170) (← links)
- Cellular, molecular, and genetic substrates underlying the impact of nicotine on learning (Q30422037) (← links)
- Nicotinic acetylcholine receptor alpha7 subunits with a C2 cytoplasmic loop yellow fluorescent protein insertion form functional receptors (Q30430585) (← links)
- Effects of prazosin, clonidine, and propranolol on the elevations in brain reward thresholds and somatic signs associated with nicotine withdrawal in rats (Q30476918) (← links)
- Noribogaine reduces nicotine self-administration in rats (Q30653279) (← links)
- Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials (Q31138857) (← links)
- Cue-induced reinstatement of nicotine-seeking behavior in rats: effect of bupropion, persistence over repeated tests, and its dependence on training dose. (Q33616676) (← links)
- Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation. (Q33738559) (← links)
- Advances in non-nicotine pharmacotherapy for smoking cessation (Q33863392) (← links)
- Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: an [11C]raclopride PET study (Q34054242) (← links)
- Effects of hydroxymetabolites of bupropion on nicotine dependence behavior in mice (Q34128836) (← links)
- Pharmacokinetic optimisation of sustained-release bupropion for smoking cessation (Q34137853) (← links)
- Nicotinic acetylcholine receptor variants are related to smoking habits, but not directly to COPD. (Q34206203) (← links)
- Chemistry and pharmacological characterization of novel nitrogen analogues of AMOP-H-OH (Sazetidine-A, 6-[5-(azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol) as α4β2-nicotinic acetylcholine receptor-selective partial agonists. (Q34215376) (← links)
- Bupropion hydro-bromide propanol hemisolvate (Q34230681) (← links)
- Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation. (Q34311649) (← links)
- In vitro and in vivo characterization of a novel negative allosteric modulator of neuronal nAChRs (Q34387101) (← links)
- Recent developments in novel antidepressants targeting α4β2-nicotinic acetylcholine receptors (Q34394190) (← links)
- Chemical stimulation of adherent cells by localized application of acetylcholine from a microfluidic system (Q34394599) (← links)
- Nicotinic receptor antagonists as treatments for nicotine abuse (Q34401397) (← links)
- The antidepressant bupropion is a negative allosteric modulator of serotonin type 3A receptors (Q34541188) (← links)
- Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent. (Q34602596) (← links)
- Neurophysiology of Nicotine Addiction (Q34637004) (← links)
- Interaction of ibogaine with human alpha3beta4-nicotinic acetylcholine receptors in different conformational states. (Q34660170) (← links)
- Bupropion: a review of its use in the management of major depressive disorder (Q34764861) (← links)
- Neuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories (Q35164053) (← links)
- Monoamine reuptake inhibitors in Parkinson's disease (Q35165280) (← links)
- Naturally-expressed nicotinic acetylcholine receptor subtypes (Q35185264) (← links)
- The possible contribution of neuronal nicotinic acetylcholine receptors in depression (Q35236613) (← links)
- Therapeutic options and challenges for substances of abuse. (Q35454891) (← links)
- Effect of bupropion treatment on brain activation induced by cigarette-related cues in smokers. (Q35545542) (← links)
- Bupropion binds to two sites in the Torpedo nicotinic acetylcholine receptor transmembrane domain: a photoaffinity labeling study with the bupropion analogue [(125)I]-SADU-3-72. (Q35860186) (← links)
- The Role of the Habenula in Nicotine Addiction (Q35875345) (← links)
- Behavioral effects of phencyclidine on nicotine self-administration and reinstatement in the presence or absence of a visual stimulus in rats. (Q35889304) (← links)
- An Experimental Study to Evaluate the Effect of Memantine in Animal Models of Anxiety in Swiss Albino Mice (Q36077324) (← links)
- Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation (Q36087706) (← links)
- Bupropion dose-dependently reverses nicotine withdrawal deficits in contextual fear conditioning (Q36103496) (← links)
- Bupropion inhibits the cellular effects of nicotine in the ventral tegmental area (Q36122868) (← links)
- Nicotinic agonists, antagonists, and modulators from natural sources (Q36216398) (← links)
- Therapeutic advances in the treatment of nicotine addiction: present and future (Q36443676) (← links)
- Central nervous system biogenic amine targets for control of appetite and energy expenditure (Q36452526) (← links)